The best health and wellness news from Washington state

Provided by AGP

Healthy Living Washington: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Washington.

Press releases published on May 13, 2026

Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
Candel Therapeutics to Present at Upcoming Investor Conferences
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
Valitor to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
Dr. Jonathan Gavras Joins Healthmap Solutions as Chief Medical Officer
Century Therapeutics Reports First Quarter Financial Results and Business Updates 
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia
Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences
INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston
Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks

Share us

on your social networks:

Sign up for:

Healthy Living Washington

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.